Merck misses £8bn in accounts
US pharmaceutical giant Merck has admitted, in a US Securities & Exchange Commission filing, that $12.4bn (£8.1bn) in reported revenues was never collected from a subsidiary.
US pharmaceutical giant Merck has admitted, in a US Securities & Exchange Commission filing, that $12.4bn (£8.1bn) in reported revenues was never collected from a subsidiary.
According to reports, subsidiary Medco, which manages pharmacy-benefit programs for businesses and health insurance companies, recorded co-payments made to pharmacies as part of its revenue, even though it did not actually receive any money paid by customers to these pharmacies.
All the money, paid by customers with a prescription drug card, went to the pharmacies with the company receiving none of it. Medco handles 65 million prescriptions a year, the second biggest in the US.
The $12.4bn worth of unclaimed revenue was reported to the SEC on Friday in an 11-K filing (annual report of employee stock purchase, savings and similar plans).
These payments totalled almost 10% of its overall reported revenue and break down as $2.8bn in 1999, $4bn in 2000 and $5.5bn in 2001.
But the company, which is audited by rapidly disintegrating and convicted firm Andersen, denied any wrongdoing in its accounts and maintained that all accounting had been done in line with US standards GAAP.
The SEC has not charged the company with any breach of accounting rules.
In the past decade, the professional services industry has transformed significantly. Digital disruptions, increased competition, and changing market ...
View resourceIn recent months, professional services firms are facing more pressure than ever to deliver value to clients. Often, clients look at the firms own inf...
View resourceIn a world of instant results and automated workloads, the potential for AP to drive insights and transform results is enormous. But, if you’re still ...
View resourceThe first phase of Making Tax Digital (MTD) saw the requirement for the digital submission of the VAT Return using compliant software. That’s now behi...
View resourceThe ICAEW confirms new vice president, with senior heads appointed at KPMG and EY. Within the mid market, a flurry of end of year partner appointments...
View articleThis follows an investigation into undisclosed personal loans and issues with an acquisition. Despite challenges, the company aims to achieve £1bn in ...
View articleThe ICAEW confirms new vice president, with senior heads appointed at KPMG and EY. Within the mid market, a flurry of end of year partner appointments...
View articleThere is optimism that the IPO market will rebound in the second half of 2024, driven by pent-up demand and potential improvements in economic conditi...
View articleThe ICAEW confirms new vice president, with senior heads appointed at KPMG and EY. Within the mid market, a flurry of end of year partner appointments...
View articleKPMG confirms reappointment of it's UK chair, while EY announces Janet Truncale as the next EY global chair and CEO Read More...
View articleThe ICAEW has announced the appointment of its forthcoming chief executive Read More...
View articleThe FRC has announced Richard Moriarty as its new chief executive, replacing Sir Jon Thompson Read More...
View article